Balance Sheet Breakdown: Voyager Therapeutics Inc (VYGR)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

After finishing at $3.04 in the prior trading day, Voyager Therapeutics Inc (NASDAQ: VYGR) closed at $517.98K, up 666760%. In other words, the price has increased by $666760 from its previous closing price. On the day, 0.67 million shares were traded. VYGR stock price reached its highest trading level at $3.1 during the session, while it also had its lowest trading level at $2.92.

Ratios:

Our goal is to gain a better understanding of VYGR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.10 and its Current Ratio is at 6.10. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.13.

On December 02, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $12.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’25 when Ferguson Toby sold 10,086 shares for $3.43 per share. The transaction valued at 34,595 led to the insider holds 157,914 shares of the business.

Sandrock Alfred sold 10,885 shares of VYGR for $37,336 on Apr 02 ’25. The President and CEO now owns 430,931 shares after completing the transaction at $3.43 per share. On Apr 02 ’25, another insider, Sandrock Alfred, who serves as the Officer of the company, bought 10,885 shares for $3.43 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VYGR now has a Market Capitalization of 164349104 and an Enterprise Value of -29673756. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.45 while its Price-to-Book (P/B) ratio in mrq is 0.60. Its current Enterprise Value per Revenue stands at -0.443 whereas that against EBITDA is 0.314.

Stock Price History:

The Beta on a monthly basis for VYGR is 0.82, which has changed by -0.63151366 over the last 52 weeks, in comparison to a change of 0.09544468 over the same period for the S&P500. Over the past 52 weeks, VYGR has reached a high of $9.55, while it has fallen to a 52-week low of $2.64. The 50-Day Moving Average of the stock is -8.99%, while the 200-Day Moving Average is calculated to be -40.47%.

Shares Statistics:

The stock has traded on average 517.98K shares per day over the past 3-months and 767860 shares per day over the last 10 days, according to various share statistics. A total of 55.21M shares are outstanding, with a floating share count of 45.00M. Insiders hold about 18.69% of the company’s shares, while institutions hold 62.86% stake in the company. Shares short for VYGR as of 1748563200 were 3197363 with a Short Ratio of 6.17, compared to 1745971200 on 2896692. Therefore, it implies a Short% of Shares Outstanding of 3197363 and a Short% of Float of 6.9.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.